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Abstract
Osteoporosis is a common complex disorder with reduced bone mineral density (BMD) and
increased susceptibility to fracture. Peak BMD is one of the primary determinants of osteoporotic
fracture risk, and is under substantial genetic control. Extracellular matrix, a major component of
bone, influences BMD by regulating mineral deposition and maintaining cellular activity. It
contains several SIBLING family proteins, null mutations of which cause mineralization defects in
humans. In this study, we tested 59 single-nucleotide polymorphisms (SNPs) located in the 5
SIBLING family genes (DSPP, DMP1, IBSP, MEPE and SPP1) for association with normal
variation in peak BMD in healthy men and women. We measured femoral neck (FN) and lumbar
spine (LS) areal BMD by dual energy x-ray absorptiometry (DXA) in 1,692 premenopausal
European-American women, 512 premenopausal African-American women and 715 European-
American men. SNPs were tested for association with FN and LS BMD in the 3 subsamples. In
the European-American women, we observed association (p≤0.005) with LS-BMD for SNPs in
DSPP, IBSP and MEPE, and for FN-BMD with SNPs in DMP1 and IBSP. Allele specific
regulation of gene expression (ASE) is an important mechanism in which an allele giving rise to
modest influence in transcript abundance might result in a predisposition to disease. To identify
whether there was ASE of SIBLING family genes at these SNPs, we examined 52 human bone
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samples obtained from the femoral neck during surgical hip replacement (27 female, 25 male; 44
European-American and 8 African-American). We observed unidirectional ASE for the IBSP
gene, with lower expression of the G allele compared to the A allele for SNP rs17013181. Our
data suggest that SNPs within the SIBLING genes may contribute to normal variation of peak
BMD. Further studies are necessary to identify the functional variants and to determine the
mechanisms underlying the differences in ASE and how these differences relate to the
pathophysiology of osteoporosis.
Keywords
Bone mineral density; Osteoporosis; Genetic association; SIBLING genes; Allele specific
expression
1 Introduction
Osteoporosis is a common multifactorial disorder with reduced bone mineral density (BMD)
and increased susceptibility to fracture. Peak BMD is one of the primary skeletal
determinants of osteoporotic fracture risk. Twin and family studies have shown that as much
as 80% of the normal variation of peak BMD is influenced by genetic factors [1,2].
Genome-wide association studies (GWAS) identified several single-nucleotide
polymorphisms (SNPs) that influence BMD variation but the overall variation of BMD
explained by these polymorphisms is small, indicating that there are many more genes and
genetic variants that regulate this complex trait which remain to be discovered [3,4].
Identifying the specific genes and causal allelic variants underlying peak BMD will help
reveal the pathogenesis of osteoporosis and ultimately improve diagnosis, prevention, and
treatment strategies of this complex disease.
Extracellular matrix is a major component of bone and is a highly dynamic structure [5]. It
provides a well-organized framework for bone mineralization and orchestrates many cellular
processes required for maintaining BMD. ECM contains several SIBLING (Small Integrin-
Binding LIgand N-linked Glycoprotein) family proteins including dentin
sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1), integrin-binding sialoprotein
(IBSP), matrix extracellular phosphoglycoprotein (MEPE), and secreted phosphoprotein
1(SPP1) or osteopontin (OPN) [5]. SIBLING proteins are encoded by 5 identically oriented
tandem genes clustered within an approximately 375 kb region on human chromosome
4q21-25. Previously, genome-wide association studies identified associations of DMP1,
IBSP and MEPE with BMD and/or fracture risk [3,4,6–12]. However, most of these studies
were performed in elderly (≥65 years) individuals of Caucasian ancestry. Moreover, it is
unknown which of these SIBLING gene/s underlie the association with peak BMD.
Previously, we identified genetic variants in IBSP contributing to normal variation of
femoral neck BMD in premenopausal women [10]. In this study, we expanded our analysis
to evaluate whether SNPs in the 5 SIBLING genes (DSPP, IBSP, DMP1, SPP1and MEPE)
were associated with normal variation of peak BMD in a sample of healthy young (≤45
years) European-American women, African-American women and European-American
men.
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Genetic variation or polymorphism in populations can determine phenotypic variations in
complex traits and diseases by regulating the level of gene expression. One approach to
detecting cis-acting effects on gene expression is to compare the relative expression of the
two alleles in the same heterozygous individual, known as allele specific expression (ASE).
ASE is quite common (~30%) in humans [13] and the imbalance of this expression has been
shown to contribute to the variation of heritable traits such as breast cancer, colorectal tumor
and familial ovarian cancer [14–16]. Thus, identification of allele specific gene expression
difference due to functionally important regulatory variation is important for understanding
the divergence of phenotypes among individuals, including differences in disease
susceptibility. Also, detection of alleles that modify disease risk has important implications
for how genetic variation in human may affect response to different treatments. The power
of this approach is that both alleles within the heterozygous individuals are exposed to the
same environmental, genetic and hormonal influences, which permits testing for even small
expression differences.
To identify whether there was preferential allelic expression in SIBLING genes, we
examined human bone samples obtained from the femoral neck collected during surgical hip
replacement. To our knowledge, this is the first study of ASE involving human bone
samples to identify whether any imbalance of allelic expression of SIBLING genes might
influence peak BMD.
2 Subjects and Methods
2.1 Subjects
Families consisting of healthy siblings were recruited from the State of Indiana to identify
genes contributing to BMD [17,18]. Recruitment focused on families with two or more
healthy sisters or brothers. Sisters were required to be premenopausal and within 10 years of
each other in age. Parents of the siblings were recruited for genotyping only and did not
undergo any phenotypic assessment. A detailed medical history of the siblings was obtained
through administration of health and lifestyle questionnaires. Studies were performed at the
Clinical Research Center of Indiana University School of Medicine. Informed written
consent was obtained from all subjects prior to their participation in the study. The study
was approved by the institutional review board of Indiana University.
Characteristics of study cohorts are summarized in Table 1. The sample of sisters and
brothers ranged in age from 27 to 40 and 22 to 45 years, respectively. Women who had
irregular menses or a history of pregnancy or lactation within three months prior to
enrollment were excluded; women taking oral contraceptives were not excluded. Additional
exclusion criteria included a history of chronic disease, use of medications known to affect
bone mass or metabolism, an inability to have BMD measured because of obesity, and
abnormal blood biochemistry (hypo- or hypercalcemia, abnormal thyroid function, serum
alkaline phosphatase and serum creatinine level).
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2.2 BMD, Height and Weight Measurements
Areal BMD (g/cm2) at the lumbar spine (vertebrae L2–L4) and hip (femoral neck) were
measured by dual energy x-ray absorptiometry (DXA), using DPX-L and Prodigy
instruments (GE Lunar Corp., Madison, WI). These instruments were cross-calibrated
weekly using a custom-made step-wedge phantom. There was no detectable systematic
difference between these machines over the course of the study. Siblings BMD were
measured on the same instrument, usually at the same visit. The coefficient of variation for
duplicate measurements after repositioning the subject was 0.5% for lumbar spine and 1.0%
for femoral neck. Height and weight were measured using a Harpenden stadiometer and a
Scale-Tronix weighing scale, respectively.
2.3 Association Analysis
SNPs located within the 375-kb SIBLING region were chosen for genotyping using the SNP
Tagger software [19] (Supplementary Table 1), and were designed to tag at r2 >0.9 all
variants with a minor allele frequency of at least 25% in the CEPH Utah population.
Genotyping was performed using iPLEX™ assays on the MassARRAY® platform
(Sequenom Inc., San Diego, CA). The average missing rate for the genotyping assays was
1.43%. Using one randomly selected individual in each family, each SNP was tested for
significant (p<0.001) deviation from Hardy-Weinberg equilibrium. In addition, parental
genotypes were used to identify Mendelian inconsistencies, using the program PedCheck
[20]. Inconsistent genotypes were individually reviewed and removed before data analysis.
In this sample of men and women, only age and weight were significant covariates of BMD.
Together they accounted for 18.4% of lumbar spine and 13.9% of femoral neck BMD
variation in the European-American women. Corresponding values were 17.4% and 17.5%
in the European-American men, and 10.4% and 15.0% in the African-American women, for
spine and femoral neck BMD, respectively. Height and years of oral contraceptive use were
also considered as potential covariates, but were not significant in regression models
(p>0.10) when age and weight were included. Therefore, regression residuals, representing
age- and weight-adjusted BMD, were computed separately in each of these subgroups and
used in all subsequent analyses.
Association testing was performed using a linear mixed model framework [21]. SNP
genotype was modeled as a fixed effect (taking on three levels corresponding to the
observed genotypes), and family (sibship) as a random effect in the mixed model.
Correlation between subjects in the same family was modeled by assuming an error
covariance matrix exhibiting compound symmetry. The model was fitted using the MIXED
procedure in the SAS statistical software (version 9.1, SAS Institute, Cary, NC). The mixed
model association test employs data from all siblings with both genotype and phenotype.
The proportion of BMD variation explained by each SNP was estimated by the R2 measure
for the mixed model framework [21]. This measure is analogous to the common R2 measure
in traditional ANOVA. The significant threshold for association was defined as a p-value of
0.05, correcting for independent comparisons within each of the 3 regions (Supplementary
Table 1). This corresponds to 4–6 observed SNP groupings per region (r2>0.9 for grouped
SNPs, r2<0.2 between groups). Linkage disequilibrium was calculated from the study
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sample. These results suggest a Bonferroni-corrected significance threshold of 0.01 for each
region and a conservative threshold of 0.005 across all regions.
2.4 Allele-specific Expression (ASE)
A total of 52 de-identified (information available for only age, race, sex and diagnosis)
human femoral neck bone samples were obtained during surgical hip replacement due to
osteoarthritis (n=42), degenerative joint disease (n=9) and osteoporotic fracture (n=1). The
samples included 44 European-American (24 male and 20 female) and 8 African-American
(3 male and 5 female) individuals. The bones were snap frozen in liquid nitrogen and stored
at −80°C. The bones were crushed and homogenized in liquid nitrogen using a mortar and
pestle. Genomic DNA (gDNA) was extracted from these bone samples using Gentra
Puregene Tissue kit (Qiagen, Valencia, CA). Total RNA was isolated from these bone
tissues using Trizol (Life Technologies, Grand Island, NY) followed by DNA-free (Life
Technologies, Grand Island, NY) treatment to minimize gDNA contamination. RNA was
further purified using RNeasy Mini columns (Qiagen, Valencia, CA) and tested for gDNA
contamination by PCR. Single stranded complementary DNA (cDNA) was synthesized from
total RNA with High Capacity cDNA Kit (Life Technologies, Grand Island, NY) using
random hexamers. Duplicate sets (4 replicates for each set) of cDNA samples were prepared
with or without reverse-transcriptase (RT). cDNA from ten nanograms of RNA and same
amount of gDNA were used for ASE assays using the MassArray system (Sequenom, Inc.,
San Diego, CA).
ASE can only be measured for SNPs within the RNA, and only for heterozygous
individuals. We chose 9 SNPs located in the exons of SIBLING genes (3 for IBSP, 2 each
for DSPP and SPP1, 1 for DMP1 and MEPE) using the dbSNP database (http://
www.ncbi.nih.gov/SNP/; Build 137) based on the following criteria: 1) SNP present in the
transcribed region, 2) MAF >0.05, and 3) PCR-primer design that avoided introns and did
not include adjacent SNPs that could confound results (Table 2 and Supplementary Table 2).
A multiplex iPLEX assay was designed using SpectroDesigner (Sequenom, Inc. San Diego,
CA) and analyzed by MALDI-TOF (matrix-assisted laser desorption/ionization time-of-
flight) mass spectrometry. Genotyping and allelotyping were performed by the SpectroTyper
4.0 (Sequenom, Inc. San Diego, CA). For each sample, we measured 4 replicates for gDNA
and a total of 8 replicates for cDNA (4 each from two independent reverse transcription
reactions). The mean allelic ratio for the cDNAs was normalized by the mean allelic ratio
for the heterozygous gDNAs to account for differences in the mass spectrometric properties
of the extended oligonucleotides (which are present in exactly equal amounts in the DNA).
Significance was determined by a t-test comparing the allelic ratios of the 8 duplicated
cDNA samples from an individual to the ratios for all heterozygous genomic DNAs.
3 Results
Sixty SNPs were genotyped across the SIBLING genes. One SNP, rs2045836, deviated from
Hardy-Weinberg equilibrium (p<0.001) in our sample and was not analyzed. For the regions
genotyped, linkage disequilibrium (LD) patterns (both D’ and r2) in the samples from
European-American and African-American samples were similar to respective HapMap data
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(CEPH and YRI); however, several SNPs were less informative (MAF<0.25; Supplementary
Table 1) in our cohorts than in the CEPH data used for the high-coverage tag SNP selection
(r2>0.9).
3.1 SNPs associated with lumbar spine and femoral neck BMD in European-American
women, African-American women and European-American men
Eight of the 59 analyzed SNPs showed an association (p≤0.005) with BMD in the sample of
European-American women (n=1692). Four of these SNPs were associated with lumbar
spine BMD, including one missense SNP (rs3750025) in DSPP, one missense SNP
(rs1054627) in IBSP and two SNPs (rs3903347 in intron and rs1477603 at 3’ near end) in
MEPE (Figure 1 and Supplementary Table 1). In addition, four SNPs were associated with
femoral neck BMD, including one SNP (rs2615492) located near the 5’ end of DMP1, one
missense SNP (rs1054627) in IBSP and two SNPs (rs13136331 and rs2616268) located in
the intergenic region between DMP1and IBSP genes (Figure 2 and Supplementary Table 1).
In the sample of European-American men (n=715), association (p≤0.005) was found with
lumbar spine BMD for one SNP (rs13136331) in the intergenic region between DMP1 and
IBSP genes and one SNP (rs6532013) for femoral neck BMD in the intergenic region
between DSPP and DMP1genes (Figures 1 and 2, Supplementary Table 1).
3.2 Allelic specific expression (ASE)
To identify whether there was any preferential allelic expression of the SNPs in the
SIBLING genes we selected 9 SNPs based on the criteria mentioned in the Methods. Due to
the requirement that SNPs be present in the transcribed region and limitations on PCR-
primer design we could not use the same SNPs associated with BMD for the ASE study.
However, we selected alternative ASE SNPs in the close proximity to our associated SNPs.
The number of informative heterozygotes for each SNP varied widely (Table 2 and
Supplementary Table 2). One SNP rs3750025 in DSPP had only 1 heterozygote and was
excluded from the analysis. The ASE is measured from 8 replicates of cDNA, 4 from each
of two different reverse transcription reactions, normalized to multiple replicates of different
genomic DNAs, and the significance is determined by a t-test. For the alleles reported as
significant, the SEM was in the range of 0.003 to 0.007 and the coefficient of variation (CV)
was between 0.01% to 0.06% among samples, indicating high precision and reproducibility
of ASE method employed in this study.
We detected significant unidirectional ASE (all heterozygous samples showing the same
allele either lower or higher) for 2 SNPs, one in each IBSP and SPP1. For SNP rs17013181
in IBSP, the minor allele G was expressed at lower levels than the ancestral allele A in all 18
heterozygote individuals (Figure 3A and Table 2). The magnitude of imbalance (ratio of
expression of minor and reference alleles; negative 1.08–1.28) was similar in male and
female as well as in European-Americans and African-Americans. For SNP rs6812524 in
SPP1 we detected higher expression of the minor allele A compared to the reference allele G
in all 3 heterozygote African-American females (Figure 3B and Table 2). The magnitude of
imbalance was lower (ratio of expression of minor and reference alleles; positive 1.06–1.13)
for the SNP in SPP1 compared to the SNP for IBSP gene.
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We detected significant (p<0.05) bidirectional allele specific expression for 6 other SNPs in
5 SIBLING genes (Supplementary Table 2). The direction of effect for these SNPs was not
the same for all subjects, indicating that the cis-acting element causing ASE was not the
measured SNP. Significant ASE was observed for SNP rs1054629 in IBSP in eight
heterozygous individuals, 4 who showed higher and 4 lower expression of the ancestral
allele (Supplementary Table 2). Two individuals had higher and one individual had lower
expression of the ancestral allele A for SNP rs17013182 in IBSP. For DMP1, 9 individuals
had higher and 5 individuals had lower expression of the ancestral allele G of rs2615497.
For SNP rs1126616 in SPP1, 9 individuals had higher and 5 individuals had lower
expression of the ancestral allele C. For DSPP, 4 individuals had higher and one individual
had lower expression of the minor allele of rs2736982. In addition, 4 individuals had higher
expression of the minor allele A for SNP rs17013285 in MEPE whereas 2 individuals had
lower expression of the same allele.
4 Discussion
Our results showed that several SNPs in the SIBLING region were associated with both
femoral neck and lumbar spine BMD in European-American women. We replicated some
SNPs associated with BMD from previous findings [8,11] and identified two novel SNPs
associated with femoral neck and spine BMD in this study. We also found evidence of
unidirectional allelic-specific expression and imbalance of IBSP and SPP1 genes and
detected bidirectional ASE for most of the SIBLING family genes in human bone tissue.
In the European-American women, we observed significant association of SNP rs1054627
located in IBSP with both femoral neck and spinal BMD. This SNP was significantly
associated in a genome-wide association study with femoral neck BMD in Icelanders and a
replication samples of European descent [8]. In our previous study, the same SNP was
associated with femoral neck BMD in premenopausal European- and African-American
women [10]. Furthermore, association with SNP rs1054627 was replicated in
premenopausal women with either extreme high or low hip BMD [11]. This non-
synonymous SNP (G195E) located in exon 8 results in a change from a non-hydrophilic to a
hydrophilic residue, which could alter the protein structure and/or function. In addition, we
detected 2 novel SNPs including one SNP (rs3750025) in DSPP associated with lumber
spine BMD in European-American women and one SNP (rs6532013) in the intergenic
region between DSPP and DMP1 genes associated with femoral neck BMD in European-
American men.
Regulation of gene expression is fundamental to genetic control of human phenotypic
variation and disease susceptibility [13]. Studies demonstrated the allele specific regulation
of gene expression is an important mechanism for controlling phenotypic variation
associated with complex traits and diseases [13–16]. Even an allele giving rise to modest
influence in transcript abundance might result in a predisposition to severe disease [15]. As
both alleles experience the same cellular environment and hormonal and other influences,
the expression difference is most likely responsible for phenotypic variation. The data from
this study also suggest that allele specific gene expression is common in SIBLING family
genes and their expression difference might contribute to the variation of peak BMD in
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humans. SNPs may cause differential allelic expression by several mechanisms including
influence on transcription binding sites or mRNA stability, differential mRNA processing,
and/or miRNA binding efficiency. These mechanisms may result in differences in mRNA
concentrations, which may in turn result in different protein expression and, thereby,
influence BMD.
Allele-specific gene expression detects cis-acting effects from nearby variants, because both
alleles share the same environment. Although the measured SNP could itself be the
regulatory variation, the most common mechanism for allelic imbalance is due to cis-acting
regulatory variations in strong linkage disequilibrium (LD) with the assayed SNP [13,24–
26]. Genetic variation of these nearby regulatory sequences thus could give higher
expression of the same mRNA in one person and lower expression in others. The direction
of the allelic imbalance will depend on the relationship between the regulatory variants and
the measured alleles; individuals having the allele at the regulatory variant that increases
expression will show higher expression of whichever measured (reported) allele is on the
same strand. If the allele expression imbalance for a given SNP is unidirectional showing the
over-expression of the same allele in all individuals, the cis-acting variant is likely to be in
high LD with the regulatory variants or could itself be the regulatory SNP.
Of the 9 SNPs for 5 SIBLING genes selected in this study, we detected bidirectional (both
higher and lower than expected allele ratio of 50:50) allele specific expression for 6 SNPs in
IBSP, DMP1, DSPP, MEPE and SPP1. This bidirectional ASE was observed not only in
subjects from a different ethnic background but also between individuals from the same
ethnic group. This might be due to the relationship between the measured and functional
alleles. The allele measured by the ASE assay is not necessarily the allele(s) that causes the
difference in expression; it is in cis with the functional allele(s). Therefore, in subjects
showing higher ASE expression, both measured and higher expressing functional alleles
may be on the same strand and in subjects showing lower ASE expression, the measured
allele is on the same strand with the lower expressing functional allele. In addition, we
observed evidence of unidirectional allele specific expression imbalance for SNP
rs17013181 in IBSP and for SNP rs6812524 in SPP1 (Figure 3 and Table 2). We observed
lower expression of G allele (minor allele) compared to A allele (reference allele) in all 18
heterozygote individuals (8 male European-American, 7 female European-American and 3
female African-American) for rs17013181. Although SNP rs6812524 in SPP1 was only
heterozygous in our African-American samples, we also detected ASE (lower expression of
G or minor allele and higher expression of A or reference allele) for this SNP in all 3
samples. The evidence of unidirectional allele specific expression imbalance for SNP
rs17013181 in IBSP and for SNP rs6812524 in SPP1 suggest that cis-acting functional
polymorphism or variation co-segregating with these SNPs exist within the same gene
affecting differential mRNA expression in bone. Further studies are necessary to identify
these cis-acting elements i.e. the functional variants and to determine the mechanisms
underlying the differences in allele specific expression and how these differences relate to
the pathophysiology of osteoporosis – for example by changing levels of the proteins.
Importantly, significant association of the missense SNP (rs1054627) on exon 8 in IBSP
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gene as well as clear evidence of ASE in human bone tissue raises the possibility of
important role of its allele specific regulation of BMD in humans.
IBSP is a major non-collagenous bone matrix protein involved in calcium and
hydroxyapatite binding and plays an important role in cell-matrix interactions through its
tripeptide RGD (Arg-Gly-Asp) motifs. IBSP is highly expressed in osteoblasts, osteoclasts
and hypertrophic chondrocytes. The expression of IBSP is upregulated in osteoporotic bone
[22]. Ibsp knockout mice show high trabecular bone density with impaired bone resorption
and mineralization [23]. Future functional studies are necessary to determine how SNPs in
IBSP gene and their allele specific expression difference might influence bone density.
Our study has several strengths. We included men and women of young age as well as
different ethnic groups for our analysis. In addition, measuring the allele specific expression
within the same heterozygous individual eliminates the influence of trans-acting elements as
well as environmental, physiological and experimental effects as both alleles are influenced
by the same cellular environment and hormonal and other influences. This approach also
improves sensitivity of the allele-specific imbalance measurements. However, we have
several limitations. We tested SNPs with a MAF of >0.25 for association and MAF of >0.05
for ASE analysis and thus cannot exclude the possible contributions of less common (i.e.
MAF <0.01) variants. Also, our phenotype is based on DXA measurements of BMD, which
do not provide a compartmental measurements of cortical and trabecular BMD.
Furthermore, we obtained association in sample of younger individuals whereas ASE was
tested in samples from older donors with mostly osteoarthritic anomalies.
In summary, we tested SNPs for association of SIBLING genes with variation in BMD. We
found association for lumbar spine and femoral neck BMD for several SNPs in the
SIBLING genes in the European-American men and women. In addition, we detected
bidirectional ASE for most of the SIBLING family genes in human bone suggesting that
allele specific expression difference due to genetic variation in the SIBLING genes is
common. Furthermore, we observed clear evidence of unidirectional allele specific
expression imbalance as well as association for SNP in IBSP for femoral neck and spine
BMD suggesting that expression difference in this gene might contribute to the variation of
peak BMD in allele specific manner in humans. Further studies are warranted to determine
the regulatory variations for the differential allele specific expression in this gene and the
mechanism how they influence the phenotypic variation of bone mineral density.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• We tested SNPs in the SIBLING family genes for association with normal
variation in peak BMD in humans
• In the European-American women, we observed association of SNPS in the
DMP1, DSPP, IBSP and MEPE with LS-BMD and FN-BMD
• Allele specific gene expression (ASE) is important for controlling phenotypic
variation associated with complex traits and diseases
• We examined preferential ASE for SNPs in the SIBLING family genes in
human bone samples
• We observed an allelic imbalance in mRNA expression for SNP rs17013181 in
IBSP
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Fig. 1.
SNPs associated with lumbar spine areal BMD in European-American women and
European-American men. Four SNPs were associated (p≤0.005) with lumbar spine BMD in
European-American women, including one missense SNP (rs3750025) in DSPP (A), one
missense SNP (rs1054627) in IBSP (B) and two SNPs (rs3903347 in intron and rs1477603
at 3’ near end) in MEPE (C). In the sample of European-American men, association
(p≤0.005) was found with lumbar spine BMD for one SNP (rs13136331) in the intergenic
Alam et al. Page 13
Bone. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
region between DMP1 and IBSP genes (B). Position and orientation of the genes are
indicated by the blue arrows.
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Fig. 2.
SNPs associated with femoral neck areal BMD in European-American women and
European-American men. Four SNPs were associated (p≤0.005) with femoral neck BMD in
European-American women, including one SNP (rs2615492) located near the 5’ end of
DMP1 (A), one missense SNP (rs1054627) in IBSP (B) and two SNPs (rs13136331 and
rs2616268) located in the intergenic region between DMP1and IBSP genes (B). In the
sample of European-American men, association (p≤0.005) was found for one SNP
(rs6532013) for femoral neck BMD in the intergenic region between DSPP and DMP1genes
(A). Position and orientation of the genes are indicated by the blue arrows.
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Fig. 3.
Allelic imbalance of mRNA expression in human bone tissue. Significant unidirectional
ASE (all heterozygous samples showing the same allele either lower or higher) was
observed for 2 SNPs, one in each IBSP and SPP1. For SNP rs17013181 in IBSP, the minor
allele G was expressed at lower levels than the ancestral allele A in all 18 heterozygote
individuals (A). For SNP rs6812524 in SPP1 higher expression of the minor allele A was
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observed compared to the reference allele G in all 3 heterozygote African-American females
(B).
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Table 1
Sample Characteristics
European-American Women African-
American
Women
European-
American
Men
Number of Sibling subjects 1692 512 715
Number of Families 766 236 336
Number of Genotyped Parents 634 69 233
Age (yr) 33.1 ± 7.2 33.0 ± 6.6 33.7 ± 10.9
Height (cm) 165.4 ± 6.0 164.4 ± 6.2 178.1 ± 6.9
Weight (kg) 69.8 ± 16.4 81.9 ± 19.8 87.1 ± 16.9
Spine aBMD (g/cm2) 1.27 ± 0.14 1.34 ± 0.14 1.27 ± 0.16
Femoral Neck aBMD (g/cm2) 1.02 ± 0.13 1.11 ± 0.15 1.09 ± 0.17
Mean ± SD
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